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Abstract Curcumin, a dietary pigment from the
plant Curcuma longa, inhibits cell proliferation and
induces apoptosis in different cell lines. The thera-
peutic benefit is hampered by a very low absorption
after trans-dermal or oral application. Therefore, great
efforts were undertaken to enhance the effectiveness
of curcumin. Recently, it was demonstrated that
curcumin offers the described effects also at low
concentrations (0.2–1 lg/ml) when applied in combi-
nation with UVA or visible light. The efficacy of this
combination was shown in human epidermal kerati-
nocytes and in a panel of other cell species in vitro as
well as in a xenograft tumor model with A431 tumor
cells injected subcutaneously in the flanks of NMRI
nude mice in vivo. The treatment of keratinocytes with
curcumin and light resulted in the inhibition of cell
growth, and in the induction of apoptosis, whereas no
toxic cell membrane damage was detectable. The
treatment of tumor bearing nude mice with curcumin
and visible light resulted in reduced tumor volumes,
reduced proliferation rates, and the induction of
apoptosis in the tumors. On the molecular level
inhibition of extracellular regulated kinases 1/2 and
epidermal growth factor receptor was observed which
may aid to inhibition of proliferation and induction of
apoptosis. This review covers the experiences of the
new combination treatment of human tumors.
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Introduction
Curcumin is a pharmacologically active substance
isolated from the rhizome of the plant C. longa Lin.
(Zingiberaceae family). The plant is used for thou-
sands of years as a remedy in Asian traditional
medicine (Arau´jo and Leon 2001) showing among
others anti-inflammatory and anti-oxidative activities
(Xu et al. 1997). Since knowing that curcumin inhibits
cell growth and induces apoptosis very great efforts
were made to elucidate the anti-cancer activities of
curcumin identifying the underlying cell physiological
mechanisms. In the meantime it became evident that
curcumin modulates survival-associated signal path-
ways (Chaudhary and Hruska 2003; Squires et al.
2003; Masamune et al. 2006) causing apoptosis in an
intrinsic and/or extrinsic manner depending on the cell
types studied (Bush et al. 2001; Kim et al. 2001;
Chakraborty et al. 2006; Dujic et al. 2007). The anti-
tumor effect of curcumin is documented for a lot of
different tumors (e.g. Anand et al. 2008). Considering
the low almost not existing toxicity of curcumin the
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development of new therapeutic strategies based on its
anti-tumor effects seems promising. However, the
clinical use is hampered by its low biological avail-
ability. Even after the application of high doses of
curcumin only low serum levels\2 lM can be gained
for a view hours (Shoba et al. 1998; Anand et al. 2007)
which do not show any pharmacological effect
(Rashmi et al. 2005; Zhang et al. 2010). The reasons
for this disadvantage can be found in its poor solubility
and stability in aqueous solutions (Wang et al. 1997),
and its rapid metabolism and systemic elimination
(Anand et al. 2007). In the past, different strategies
have been developed to enhance the biological
effectiveness of curcumin. One approach is the
stabilization of the molecule by complexations and
conjugations (Kumar et al. 2001; Tønnesen et al. 2002;
Safavy et al. 2007). Alternatively, curcumin contain-
ing nanoparticles with different strategies concerning
the drug release of the compound are tested (Safavy
et al. 2007; Yan et al. 2012b, 2010). Another strategy
has already entered clinical trials utilizing inhibitors of
curcumin metabolizing enzymes like the black pepper
alkaloid piperine (Shoba et al. 1998; Singh et al.
2012). In addition numerous analogues of curcumin
have been constructed and investigated with regards to
stability of the molecule, bioavailability, and anti-
cancer activity (Ferrari et al. 2011; Ohori et al. 2006;
Ohtsu et al. 2002). When Thomas Dahl published his
work about the photokilling of bacteria by curcumin
(Dahl et al. 1989) a further way to enhance curcumin
driven effects arose. During the following years plenty
of studies appeared documenting the antimicrobial
effect of curcumin combined with light (e.g. Haukvik
et al. 2010, 2009; Hegge et al. 2012; Arau´jo et al.
2012; Dovigo et al. 2011a, b) followed by works about
the anticancer effects of curcumin and light in
eukaryotic cell systems. This review will sum up the
present knowledge focusing on light dependent effects
of low curcumin concentrations in human cells and
tumor cells.
Effect of light and curcumin on cell proliferation
and viability
The treatment of HaCaT keratinocytes or primary
keratinocytes with low doses (0.1–1 lg/
ml = 0.27–2.7 lM) of curcumin did not show any
influence on the DNA synthesis as marker for cell
proliferation. Interestingly, irradiation of keratino-
cytes with UVA (1 J/cm2) or with visible light
(5,500 lx) after treating the cells for 2 h with curcumin
resulted in a clear inhibition of DNA synthesis starting
already at 0.2 lg/ml curcumin indicating a strong
inhibition of cell proliferation by such a combination.
The chosen experimental conditions did not induce
toxic membrane damage and no elevated ROS were
detected. To see whether the light depending effect is
cell type specific, different cell types were tested
including primary skin fibroblasts, melanocytes, mel-
anoma cells (G-361), and A-431 cells. In all cases the
combination of low curcumin concentrations with
light inhibited the proliferation of the tested cells
(Dujic et al 2007). Similar results were gained with
nasopharyngeal carcinoma cells. The cytotoxicity of
curcumin on the cells was enhanced by irradiation
with visible light and blue filtered light (Koon et al.
2006). Furthermore, the combination of curcumin with
visible light resulted in a remarkable photocytotoxic-
ity in HeLa cells (Banerjee et al. 2012), L929
fibroblasts (Ribeiro et al. 2012) and Lewis lung
carcinoma cells (Yan et al. 2012a). In all studies
described above, curcumin was combined with visible
light or UVA in regard to the maximum light
absorbance of curcumin at about 420 nm. Dujic
et al. (2007) did not find any enhanced growth
inhibiting effect if low concentrations of curcumin
were combined with UVB. However, Park and Lee
(2007) described a photodynamic effect of curcumin
using UVB as light source in the presence of higher
curcumin concentrations. From my point of view, the
effects of low doses of curcumin can be amplified via
light of wavelengths near the absorbance maximum of
curcumin because the maximum intake of light energy
is ensured under these conditions. In case of UVB and
high curcumin concentrations maybe different anti-
proliferative mechanisms are induced independently
resulting in an additive enhancement of growth
inhibition and apoptosis induction.
Effect of light and curcumin on signal transduction
pathways
It is well known that the NF-jB transcription factor
can be inhibited by high concentrations of curcumin in
various cell types (Singh and Aggarwal 1995; Jobin
et al. 1999). Both, UVA and visible light strongly
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inhibit NF-jB in combination with low doses of
curcumin in a concentration dependent manner (Dujic
et al. 2007). In addition curcumin/UVA treatment of
HaCaT cells show a clear increase of IjB-alpha
indicating that low doses of curcumin combined with
light suppress the survival factor NF-jB in a dual
manner by suppressing the activation of NF-jB and
enhancing the inhibitor of NF-jB (IjB-alpha) (Dujic
et al. 2007). Furthermore, it was demonstrated that
curcumin at low doses in combination with light
inhibits the growth/survival kinases PKB/Akt, ERK1/
2 and the related upstream receptor EGF-R (Dujic
et al. 2007). The suppression of these proliferation
associated pathway components can also be gained
using high concentrations of curcumin without light
irradiation (Squires et al. 2003; Kim et al. 2001;
Chaudhary and Hruska 2003) but the combination of
curcumin treatment with light enables a huge sensi-
tization of the curcumin effects on this signal pathway.
Effect of light and curcumin on apoptosis
One of the most interesting anti-cancer effects of
curcumin is the induction of apoptosis which can be
initiated with high concentrations of curcumin by both,
the extrinsic and/or intrinsic way (Kim et al. 2001;
Bush et al. 2001) depending from cell type and tissues.
For the first time Dujic et al (2007) showed that this
important anti-cancer machinery can be triggered by
low curcumin concentrations if treatment is combined
with UVA or visible light irradiation. Staining of nuclei
by bisbenzimide revealed a marked increase of apop-
totic nuclei in HaCaT cells 24 h after treatment with
UVA (1 J/cm2) and 1 lg/ml curcumin. To elucidate
the mechanism, the release of cytochrome c and the
activation of caspases were investigated. Curcumin
with light induced in HaCaT keratinocytes the release
of cytochrome c from mitochondria and the activation
of caspases 8, 9 and 3. Interestingly, a time-dependent
dichotomy between intrinsic and extrinsic apoptosis
markers could be found given that caspase 9 was
activated half an hour before activation of caspase 8.
Light protected controls did not show any curcumin-
induced caspase activation or cytochrome c release in
the tested concentration range. Similar results were
described by Park and Lee (2007) who treated HaCaT
cells with curcumin (5–10 lM) and subsequently
irradiated cells with UVB. The authors suppose a
synergistic effect of curcumin and UVB and speculate
that curcumin may be clinically useful as a photosen-
sitizer in photodynamic therapy (PDT).
Effect of light and curcumin on tumor cells in vivo
To investigate whether the combined treatment of
tumors with curcumin and visible light brings an
advantage over the treatment with curcumin alone a
xenograft tumor model was used. For this purpose
A431 tumor cells were injected subcutaneously into
the flanks of nude mice and the tumor growth was
investigated in untreated control animals, in animals
irradiated with visible light, in light protected but
curcumin treated animals, and in animals intraperito-
neally injected with curcumin and irradiated with
visible light (for details s. Dujic et al. 2009). Only the
combination of curcumin treatment with visible light
resulted in a significant inhibition of tumor growth
compared to the control groups. The average tumor
volume at day 12 in curcumin/light treated mice was
reduced by approximately 70 % in comparison with
the untreated control group. Immunohistochemical
and biochemical investigations of the tumor tissue
revealed a reduction of Ki67 positive cells, a signif-
icant decrease in phosphorylation of ERK1/2 and
EGF-R as well as an activation of caspase-9 in the
tumors of the curcumin/light treated group compared
to controls (Dujic et al. 2009). These results show
clearly that combination of light and curcumin ampli-
fies the anti-growth and pro-apoptotic effects of
curcumin in a tumor model in vivo.
Cell-specific action of curcumin
A lot of studies indicate a selective effectiveness of
curcumin towards cancer cells compared with normal
cells (for references s. Ravindran et al. 2009). The
reason for the different sensibility to curcumin treat-
ment is not fully understood. An enhanced cellular
uptake of curcumin in tumor cells is discussed
(Kunwar et al. 2008). Another consideration is that,
in contrast to normal cells, most tumor cells express
constitutively active NF-kB mediating their survival.
The NF-kB down regulation is one of the main effects
of curcumin. However, the treatment of different cell
lines with curcumin combined with UVA or visible
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light irradiation induced growth inhibition and apop-
tosis induction in all tested cells including normal
keratinocytes, A431 epidermoid carcinoma cells,
HaCaT-keratinocytes, normal fibroblasts, normal mel-
anocytes and different melanoma cell lines (Dujic
et al. 2007, and unpublished results). Further investi-
gations are necessary to elicit if also this curcumin
based therapy concept may operate selectively.
Molecular action of curcumin
The chemical structure of curcumin, bis(4-hydroxy-3-
methoxyphenyl)-1,6-diene-3,5-dione (Fig. 1), was
elucidated by Lampe and Milobedzka (1913) and
further described in detail under different physical
conditions by Roughley and Whiting (1973). The
molecule contains functional parts like phenoxy
groups, methoxy groups and the tautomerism between
enol- and keto-structures. The energetically more
stable enol-form is stabilized by intramolecular
hydrogen boundings which may be partly responsible
for its biological effects. The double bindings of the
aliphatic chain between the two phenol rings are
important for the mode of action of curcumin. After
elimination of the double bonds the apoptosis inducing
activity of curcumin was lost (Pae et al. 2007). The
anti-oxidative and the radical scavenger properties of
curcumin are thought to be supported by the phenoxy
groups (Arau´jo and Leon 2001). Other authors show
that curcumin can also act as a radical donor. High
concentrations of curcumin enhance the intracellular
concentration of ROS subsequently causing the
induction of cell cycle arrest and apoptosis (Chen
et al. 2010; Weir et al. 2007). The radical transmitting
effect of curcumin can be enhanced by light leading to
an effective photochemical strategy against microor-
ganisms (Arau´jo et al. 2012, Dahl et al. 1994).
However, at low concentrations the radical scavenging
property of curcumin seems to be predominant
(Premanand et al. 2006) even in combination with
light (Dujic et al. 2007). No significant induction of
ROS was detected by treatment of cells with low doses
of curcumin alone or in combination with 1 J/cm2
UVA. On the contrary, when ROS generation was
induced with high doses UVA (20 J/cm2) curcumin
reduced UVA induced ROS in a concentration
dependent manner using 0.2–1 lg/ml curcumin (Dujic
et al. 2007). Therefore, I suppose that low doses of
curcumin combined with 1 J/cm2 UVA or visible light
induce apoptosis by other mechanisms than by ROS
generation. In addition, the impact of different curcu-
min concentrations on cell membrane structure was
demonstrated using a combination of solid-state NMR
and different scanning calorimetry techniques. It was
shown that curcumin disturbs the membrane fluidity
and changes the conformation and function of integral
membrane proteins dependent from the concentration
used (Barry et al. 2009; Ingolfsson et al. 2007).
Despite intensive efforts to elucidate the exact chem-
ical mode of action and the role of light in the
enhancing effect of curcumin, a major molecular
mechanism could not be identified so far and further
investigations are indispensable. Interestingly, photo-
bleaching of curcumin resulted in a total loss of its
light dependent anti-tumor activities (Dujic 2008).
Curcumin binds directly to a lot of different proteins
including signaling molecules, enzymes and carrier
proteins (reviewed in Gupta et al 2011). The close
proximity in curcumin-protein complexes makes
light driven interactions most likely. Barik et al.
(2003) investigated the binding of curcumin on
proteins using BSA. They showed a high affinity of
curcumin to BSA accompanied by a strong enhance-
ment of fluorescence emission and a blue-shift of the
fluorescence spectrum of curcumin. Considering
these findings a light dependent energy transfer via
curcumin may enhance the influence of curcumin on
protein functions resulting in the described effects
on cell physiology. However, this hypothesis needs
further investigations.Fig. 1 Chemical structure of curcumin
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Conclusions and perspectives
In vitro- and in vivo-experiments showed that very
low concentration of curcumin is sufficient to induce
anti-tumor effects if the treatment is combined with
UVA or visible light irradiation. The used doses of
visible light or UVA alone did not show any signif-
icant anti-tumor effects. Just the combination of light
with curcumin induced the described anti-tumor
activities. The influence of low curcumin concentra-
tions combined with light on key factors of growth and
apoptosis was shown in vivo and in vitro (Fig. 2).
Consequently, the difficulty of the low bioavailability
of curcumin can be compensated by a combination of
curcumin with light treatment. The pre-clinic exper-
iments argue for starting the development of clinical
therapy concepts based on curcumin and light. Further
investigations are necessary to elucidate the physico-
chemical mechanism of light dependent curcumin
effects.
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